TOP MEDICAL NEWS 10/AUGUST/2022

Published On 2022-08-10 10:20 GMT   |   Update On 2022-08-10 10:20 GMT

1.Robotic-assisted lobectomy for early-stage lung cancer provides better patient-reported quality of life compared to video-assisted lobectomy.Dr. Patel and colleagues reported that the study sought to determine the difference in patient-reported health-related quality of life (HRQOL) between robot-assisted surgery and video-assisted surgery at 12 weeks after surgery and incremental cost...

Login or Register to read the full article

1.Robotic-assisted lobectomy for early-stage lung cancer provides better patient-reported quality of life compared to video-assisted lobectomy.

Dr. Patel and colleagues reported that the study sought to determine the difference in patient-reported health-related quality of life (HRQOL) between robot-assisted surgery and video-assisted surgery at 12 weeks after surgery and incremental cost per quality-adjusted life year (QALY) at 12 months after surgery.

Dr. Patel, from four academic sites in the United States, Canada, and France enrolled 406 patients with early-stage lung cancer who were candidates for minimally invasive lobectomy. Patients were randomized to receive either RTS-Lobectomy which is intervention or VATS-Lobectomy thats is control.

Ref:

Dr. Yogita S. Patel et. al, INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER, MEETING IASLC World Conference on Lung Cancer 2022, 9-AUG-2022

2. Risk factors for patients with lung cancer who have never smoked

To assess the connection between pollution and lung cancer diagnosis, Renelle Myers and their team compared the cumulative three-year versus 20-year exposure in females with newly diagnosed lung cancer who have never smoked.

The researchers collected detailed information on the patient's age, sex, race, country of birth, age of arrival in Canada (for foreign-born Canadians), occupation, family history of lung cancer, and secondhand smoke exposure. A detailed residential history from birth to cancer diagnosis for residences within Canada, and prior residences outside of Canada (for foreign-born immigrants) were recorded.

Ref:

Renelle Myers et. al, MEETING IASLC World Conference on Lung Cancer 2022,

3. High Sexual dysfunction among women with lung cancer

Sexual dysfunction is highly prevalent in women with lung cancer with most survey participants reporting little to no interest in sexual activity, according to research led by Narjust Florez.

Reporting results of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) study, researchers show marked differences in sexual desire/interest and vaginal pain/discomfort when comparing before and after a lung cancer diagnosis.

The SHAWL study is an observational, cross-sectional, international survey administered via the GO2 Foundation for Lung Cancer and the Lung Cancer Registry. The study utilized the Patient-Reported Outcomes Measurement Information System (PROMIS®) Sexual Function and Satisfaction Measures (a validated questionnaire) to evaluate sexual health.

Ref:

Narjust Florez et. al, Sexual dysfunction high among women with lung cancer, DANA-FARBER CANCER INSTITUTE,9-AUG-2022

4. Lung cancer risk prediction nomogram for female non-smokers

About 53% of lung cancers in females are not attributable to smoking worldwide and a new model presented at the IASLC World Conference on Lung Cancer may allow clinicians the ability to assess and stratify lung cancer risk in female non-smokers in China.

Lanwei Guo, & team examined data from 151,834 patients in China, from October 2013 to October 2019 from the Cancer Screening Program in Urban China.

The aim was to develop and validate a simple and non-invasive model which could assess and stratify lung cancer risk in female non-smokers in China. Ref:

Lanwei Guo et. al, MEETING, IASLC World Conference on Lung Cancer 2022, 9-Aug-2022

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Medical Bulletin 18/ May/ 2024
Medical Bulletin 17/ May/ 2024
Medical Bulletin 16/ May/ 2024
Medical Bulletin 14/ May/ 2024
Medical bulletin 13/ May/ 2024
Medical Bulletin 11/ May/ 2024
Medical Bulletin 10/ May/ 2024
Medical Bulletin 09/ May/ 2024